EyePoint Pharmaceuticals (EYPT) Insider Trading & Ownership → Urgent alert: open this for a huge profit potential (From Timothy Sykes) (Ad) Free EYPT Stock Alerts $9.10 -0.17 (-1.83%) (As of 06/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EyePoint Pharmaceuticals (NASDAQ:EYPT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.74%Number OfInsiders Buying(Last 12 Months)6Amount OfInsider Buying(Last 12 Months)$89.50 MNumber OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$49.45 M Get EYPT Insider Trade Alerts Want to know when executives and insiders are buying or selling EyePoint Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address EYPT Insider Buying and Selling by Quarter Ad Porter & CompanyThe only AI company to buyThe AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. EyePoint Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/14/2024David R GuyerDirectorSell11,625$12.65$147,056.25 5/6/2024Cormorant Asset Management, LpMajor ShareholderBuy850,000$11.86$10,081,000.00 4/18/2024Cormorant Asset Management, LpMajor ShareholderBuy581,765$18.03$10,489,222.95 2/2/2024David Scott JonesSVPSell209$28.49$5,954.41 1/26/2024Dario A PaggiarinoInsiderSell49,325$25.66$1,265,679.50 1/25/2024David Scott JonesSVPSell600$25.00$15,000.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/23/2024Dario A PaggiarinoInsiderSell5,135$25.00$128,375.00 1/23/2024David Scott JonesSVPSell900$25.00$22,500.00 1/11/2024Cormorant Asset Management, LpMajor ShareholderBuy750,000$19.75$14,812,500.00 1/11/2024Ye LiuDirectorSell1,910,500$19.45$37,159,225.00 1/9/2024Cormorant Asset Management, LpMajor ShareholderBuy105,000$21.32$2,238,600.00 1/8/2024Dario A PaggiarinoInsiderSell22,913$21.13$484,151.69 12/13/2023Dario A PaggiarinoInsiderSell1,458$20.00$29,160.00 12/8/2023Cormorant Asset Management, LpMajor ShareholderBuy588,235$17.00$9,999,995.00 12/6/2023Ye LiuDirectorSell266,242$18.41$4,901,515.22 12/4/2023Cormorant Asset Management, LpMajor ShareholderBuy1,919,057$21.82$41,873,823.74 12/4/2023Michael Craig PineInsiderSell45,000$22.00$990,000.00 9/1/2023Ew Healthcare Partners, L.P.Major ShareholderSell20,000$9.90$198,000.00 8/30/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,976$10.92$665,857.92 8/28/2023Ew Healthcare Partners, L.P.Major ShareholderSell60,858$11.71$712,647.18 8/24/2023Ew Healthcare Partners, L.P.Major ShareholderSell139,280$14.62$2,036,273.60 8/22/2023Ew Healthcare Partners, L.P.Major ShareholderSell46,778$14.62$683,894.36 (Data available from 1/1/2013 forward) EYPT Insider Trading Activity - Frequently Asked Questions Who is on EyePoint Pharmaceuticals's Insider Roster? The list of insiders at EyePoint Pharmaceuticals includes Cormorant Asset Management, Lp, Dario A Paggiarino, David R Guyer, David Scott Jones, Ew Healthcare Partners, L.P., Michael Craig Pine, and Ye Liu. Learn more on insiders at EYPT. What percentage of EyePoint Pharmaceuticals stock is owned by insiders? 4.74% of EyePoint Pharmaceuticals stock is owned by insiders. Learn more on EYPT's insider holdings. Which EyePoint Pharmaceuticals insiders have been buying company stock? The following insider purchased EYPT shares in the last 24 months: Cormorant Asset Management, Lp ($89,495,141.69). How much insider buying is happening at EyePoint Pharmaceuticals? Insiders have purchased a total of 4,794,057 EYPT shares in the last 24 months for a total of $89,495,141.69 bought. Which EyePoint Pharmaceuticals insiders have been selling company stock? The following insiders have sold EYPT shares in the last 24 months: Dario A Paggiarino ($1,907,366.19), David R Guyer ($147,056.25), David Scott Jones ($43,454.41), Ew Healthcare Partners, L.P. ($4,296,673.06), Michael Craig Pine ($990,000.00), and Ye Liu ($42,060,746.22). How much insider selling is happening at EyePoint Pharmaceuticals? Insiders have sold a total of 2,641,800 EyePoint Pharmaceuticals shares in the last 24 months for a total of $49,445,296.13 sold. More Insider Trading Tools from MarketBeat Related Companies: LAB Insider Trades CTKB Insider Trades QTRX Insider Trades PACB Insider Trades NAUT Insider Trades HBIO Insider Trades SEER Insider Trades AKYA Insider Trades BNGO Insider Trades RPID Insider Trades Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (NASDAQ:EYPT) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding EyePoint Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share EyePoint Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.